Patients with thyroid cancer are often assumed to have no quality of life (QOL) impairments after treatment because of thyroid cancer’s good prognosis. However, the QOL implications of surgical complications and the necessity to take lifelong medication are seldom assessed.
Patients who had surgery due to thyroid cancer at the University Medical Center Mainz between 2010 and 2015 and who had calcium or parathyroid hormone levels below the reference values immediately following surgery were eligible for this study. QOL was assessed using the EORTC QLQ-C30 and the thyroid cancer module EORTC QLQ-THY34. Multiple logistic regression was used to determine factors associated with a worse QOL compared with a general population.
A total of 75 (56%) of 134 eligible patients participated in the study. Patients with persistent/prolonged calcium or vitamin D intake reported worse QOL in the domains of global health, physical functioning, role functioning, emotional functioning, and insomnia than patients without current intake. Current calcium and vitamin D intake, higher education, living with a partner, and age had an effect on the odds of having worse QOL than the age- and sex-adjusted general population.
Prolonged calcium and/or vitamin D intake are negatively associated with certain domains of QOL in thyroid cancer patients who are at least 1 year post surgery. Assessment of calcium and vitamin D and diagnosis of hypoparathyroidism are therefore important for the follow-up of thyroid cancer survivors since it may affect their QOL.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403
Brown RL, de Souza JA, Cohen EE (2011) Thyroid cancer: burden of illness and management of disease. J Cancer 2:193–199
Wu LM, Gu HY, Qu XH, Zheng J, Zhang W, Yin Y et al (2012) The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: a meta-analysis. Eur J Radiol 81(8):1798–1805
Pacini F, Castagna MG, Cipri C, Schlumberger M (2010) Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol) 22(6):475–485
Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S et al (2009) The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One 4(1):e4191
Gamper EM, Wintner LM, Rodrigues M, Buxbaum S, Nilica B, Singer S et al (2015) Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme. Eur J Nucl Med Mol Imaging 42(8):1179–1188
Singer S, Lincke T, Gamper E, Bhaskaran K, Schreiber S, Hinz A et al (2012) Quality of life in patients with thyroid cancer compared with the general population. Thyroid. 22(2):117–124
Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV (2011) Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol 75(4):544–554
Husson O, Haak HR, Buffart LM, Nieuwlaat WA, Oranje WA, Mols F et al (2013) Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol 52(2):249–258
Hedman C, Djarv T, Strang P, Lundgren CI (2016) Determinants of long-term quality of life in patients with differentiated thyroid carcinoma—a population-based cohort study in Sweden. Acta Oncol 55(3):365–369
Hoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA, Smit JW (2008) Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93(1):200–203
Bergenfelz A, Jansson S, Kristoffersson A, Martensson H, Reihner E, Wallin G et al (2008) Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbeck's Arch Surg 393(5):667–673
Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H (2003) The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 133(2):180–185
Chadwick DR (2017) Hypocalcaemia and permanent hypoparathyroidism after total/bilateral thyroidectomy in the BAETS registry. Gland Surg 6(Suppl 1):S69–S74
Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W et al (2015) European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173(2):G1–G20
Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV et al (2016) Management of Hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 101(6):2273–2283
Marcucci G, Della Pepa G, Brandi ML (2016) Natpara for the treatment of hypoparathyroidism. Expert Opin Biol Ther 16(11):1417–1424
Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D et al (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26(10):2317–2337
Shoback D (2008) Clinical practice. Hypoparathyroidism. N Engl J Med 359(4):391–403
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28(11):2277–2285
Almquist M, Ivarsson K, Nordenstrom E, Bergenfelz A (2018) Mortality in patients with permanent hypoparathyroidism after total thyroidectomy. Br J Surg 105(10):1313–1318
Buttner M, Musholt TJ, Singer S (2017) Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine. 58(1):14–20
Singer S, Husson O, Tomaszewska IM, Locati LD, Kiyota N, Scheidemann-Wesp U et al (2016) Quality-of-life priorities in patients with thyroid cancer: a multinational European Organisation for Research and Treatment of Cancer phase I study. Thyroid 26(11):1605–1613 (2016)
Singer S, Jordan S, Locati LD, Pinto M, Tomaszewska IM, Araujo C et al (2017) The EORTC module for quality of life in patients with thyroid cancer: phase III. Endocr Relat Cancer 24(4):197–207
Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treamtent of Cancer, Brussels
Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37(11):1345–1351
https://www.r-project.org/foundation/ (last access: 13.07.2019)
Banach R, Bartes B, Farnell K, Rimmele H, Shey J, Singer S et al (2013) Results of the Thyroid Cancer Alliance international patient/survivor survey: psychosocial/informational support needs, treatment side effects and international differences in care. Hormones (Athens) 12(3):428–438
McIntyre C, Jacques T, Palazzo F, Farnell K, Tolley N (2018) Quality of life in differentiated thyroid cancer. Int J Surg 50:133–136
Aschebrook-Kilfoy B, James B, Nagar S, Kaplan S, Seng V, Ahsan H et al (2015) Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American Thyroid Cancer Survivorship study. Thyroid. 25(12):1313–1321
Malterling RR, Andersson RE, Falkmer S, Falkmer U, Nilehn E, Jarhult J (2010) Differentiated thyroid cancer in a Swedish county—long-term results and quality of life. Acta Oncol 49(4):454–459
Pelttari H, Sintonen H, Schalin-Jantti C, Valimaki MJ (2009) Health-related quality of life in long-term follow-up of patients with cured TNM stage I or II differentiated thyroid carcinoma. Clin Endocrinol 70(3):493–497
Roberts KJ, Lepore SJ, Urken ML (2008) Quality of life after thyroid cancer: an assessment of patient needs and preferences for information and support. J Cancer Educ 23(3):186–191
Applewhite MK, James BC, Kaplan SP, Angelos P, Kaplan EL, Grogan RH et al (2016) Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg 40(3):551–561
Rogers SN, Mepani V, Jackson S, Lowe D (2017) Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer. Br J Oral Maxillofac Surg 55(7):666–673
Schultz PN, Stava C, Vassilopoulou-Sellin R (2003) Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck 25(5):349–356
Bago AG, Dimitrov E, Saunders R, Seress L, Palkovits M, Usdin TB et al (2009) Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience. 162(1):128–147
Balabanov S, Tollner U, Richter HP, Pohlandt F, Gaedicke G, Teller WM (1984) Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol 106(2):227–233
Divieti P, Inomata N, Chapin K, Singh R, Juppner H, Bringhurst FR (2001) Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology. 142(2):916–925
Usdin TB, Bonner TI, Hoare SR (2002) The parathyroid hormone 2 (PTH2) receptor. Receptors Channels 8(3–4):211–218
Taieb D, Baumstarck-Barrau K, Sebag F, Fortanier C, De Micco C, Loundou A et al (2011) Heath-related quality of life in thyroid cancer patients following radioiodine ablation. Health Qual Life Outcomes 9:33
Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W et al (2006) Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 15(4):695–703
James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P et al (2018) Quality of life in thyroid cancer-assessment of physician perceptions. J Surg Res 226:94–99
This study was funded by the MAIFOR program of the Johannes Gutenberg-University Mainz, Germany.
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures involving human participants in this study were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
This study was approved by the Ethics-Committee of the Landesärztekammer Rhineland-Palatinate (# 837.238.16).
Informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Büttner, M., Hinz, A., Singer, S. et al. Quality of life of patients more than 1 year after surgery for thyroid cancer. Hormones 19, 233–243 (2020). https://doi.org/10.1007/s42000-020-00186-x
- Quality of life
- Thyroid cancer
- Vitamin D